RHO and retinitis pigmentosa 1: Nevertheless, our results indicate that both JC3 and JC4 are good lead compound candidates for the development of next generation more effective pharmacochaperones that stabilize the rod opsin protein, enhance photoreceptor survival, and ultimately slow down the progression of Rho-related RP.